Ligand validation:6C3I

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6C3I designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6C3I_OLC_A_501	11%	54%	0.292	0.813	0.82	0.93	2	1	2	0	100%	1
6C3I_OLC_B_502	7%	54%	0.339	0.801	0.81	0.95	2	1	3	0	100%	1
6C3I_OLC_A_503	6%	48%	0.324	0.806	0.96	1.05	2	1	1	0	72%	0.72
6C3I_OLC_A_502	4%	52%	0.353	0.771	0.9	0.94	2	1	1	0	80%	0.8
6C3I_OLC_A_504	2%	55%	0.531	0.801	0.81	0.91	2	1	1	0	100%	1
6C3I_OLC_B_501	2%	54%	0.539	0.794	0.81	0.94	2	1	0	0	100%	1
8E6N_OLC_A_510	31%	71%	0.129	0.91	0.29	0.8	-	-	1	0	36%	0.36
8E5V_OLC_A_506	30%	49%	0.167	0.881	0.95	1.03	2	1	0	0	72%	0.72
8E6L_OLC_A_504	27%	50%	0.222	0.903	0.89	1.04	2	1	0	0	80%	0.8
6D91_OLC_A_504	23%	38%	0.17	0.878	1.09	1.39	2	1	2	0	52%	0.52
8E6M_OLC_A_510	23%	54%	0.2	0.819	0.81	0.98	1	1	1	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.